NIH kicks off extra COVID-19 vaccine dose trial with autoimmune patients

The National Institutes of Health has announced the start of a new trial that involves giving a third COVID-19 vaccine dose to individuals with autoimmune diseases. The trial will also look into the possibility of ‘pausing’ autoimmune treatments that involve immunosuppressive drugs to see whether doing so will improve antibody response against the SARS-CoV-2 virus. The third COVID-19 vaccine dose …